Lek's Acyclovir Successful on US Market
Ljubljana, 4 August - SLOVENIA/PHARMACY/LEK/USA
Slovene pharmaceutical company Lek Ljubljana gained a 40 percent share of the US market in the sale of Acyclovir tablets and capsules. Acyclovir is an anti-virotic, used primarily for curing herpes and chicken-pox.
The rest of this news item is available to subscribers.
The news item consists of 375 characters (without spaces) or 74 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.